Dapirolizumab pegol as an add-on treatment in adults and teens with moderate to severe SystemicLupus Erythematosus (SLE)
Drugs: Dapirolizumab pegol
Trial ID: PHOENYCS FLY STUDY for Adults & Teens Living with Lupus – SL0044
Age: 16+ Years Old
Phase: 3
